Muscle News and Research

RSS

HCT 1026 may help stem debilitating effects of muscular dystrophy

Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder.

9 Nov 2012

Low antioxidant levels contribute to increased blood pressure during exercise for people with PAD

Low antioxidant levels contribute to increased blood pressure during exercise for people with peripheral arterial disease, according to researchers at Penn State Hershey Heart and Vascular Institute.

8 Nov 2012

Exercise benefits physical, mental health in schizophrenia

Exercise therapy improves mental health and cardiovascular fitness in patients with schizophrenia, researchers report.

8 Nov 2012

Cardiac arrhythmias: an interview with Dr Andrew Grace

Cardiac arrhythmias are disturbances of the heartbeat. The heart can either go too slowly, which might make people collapse or exhausted; or too quickly.

8 Nov 2012

Better understanding of clotting dynamics in atherosclerosis could lead to more effective drugs

The disease atherosclerosis involves the build up of fatty tissue within arterial walls, creating unstable structures known as plaques. These plaques grow until they burst, rupturing the wall and causing the formation of a blood clot within the artery. These clots also grow until they block blood flow; in the case of the coronary artery, this can cause a heart attack.

8 Nov 2012

Nanofiber technique to build new nerves from stem cells

Every week in his clinic at the University of Michigan, neurologist Joseph Corey, M.D., Ph.D., treats patients whose nerves are dying or shrinking due to disease or injury.

8 Nov 2012

BMI may not be best measure for estimation of cancer risk

A study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that body mass index (BMI)-the most commonly used weight-for-height formula for estimating fatness-may not be the best measure for estimating disease risk, and particularly the risk of certain types of cancer. The study was published today in the online edition of the American Journal of Epidemiology.

8 Nov 2012

Scientists show how sorafenib can be dangerous to the heart

Scientists for the first time have evidence showing how a widely used type of "targeted" cancer drug can be dangerous to the heart.

7 Nov 2012

Economic impact of acute coronary syndrome goes beyond hospitals to homes and workplaces

The economic impact of a heart attack and other forms of acute coronary syndrome goes beyond the hospital to the home and workplace, according to research presented at the American Heart Association's Scientific Sessions 2012.

7 Nov 2012

Drug trio may reduce eliminate cardiac side effects of doxorubicin

Combining cancer medication with a drug for erectile dysfunction and one for heart transplants helped kill cancer cells and protected the heart from damage, in a study presented at the American Heart Association's Scientific Sessions 2012.

7 Nov 2012

Degeneration of serotonergic neurons linked to spasticity in ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an occurrence rate in France similar to multiple sclerosis (two to three new cases per year for every 100,000 residents). It has a specific affect on neurons responsible for motor control, in particular motor neurones and central motor neurones. The former, located in the spinal cord, are directly linked to muscles and are used for muscle contraction and stretching.

7 Nov 2012

Loyola announces 2012 Junior and Senior Scientist of the Year during St. Albert's Day

Katherine L. Knight, PhD, one of the nation's leading immune system researchers, has been named 2012 Senior Scientist of the Year at Loyola University Chicago Stritch School of Medicine. Sakthivel Sadayappan, PhD, FAHA, who is doing groundbreaking research on a protein that is critical for the normal functioning of the heart, has been named 2012 Junior Scientist of the Year.

7 Nov 2012

Positive results from BioCardia's Helical Infusion System Phase 1/2 trial on ischemic cardiomyopathy

BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection.

7 Nov 2012

Turning off GSK-3α protein activity can prevent heart remodeling

When a person has a heart attack, portions of the heart muscle die in the next several days or even weeks if deprived of oxygen for long enough. The recovering heart slowly remodels itself, even fostering the growth of new blood vessels, in an attempt to regain some of its former function. But all too often, the remodeling is actually harmful, and the damaged heart is on an inevitable downward slide to heart failure.

6 Nov 2012

Physical exercise may help preserve mobility in Parkinson’s patients

Aerobic and resistance exercise significantly improve fitness, gait speed, and muscle strength in patients with Parkinson’s disease, shows research published in the Archives of Neurology.

6 Nov 2012

Midwest symposium to discuss new concepts for tissue-specific regenerative medicine

Hoxworth Blood Center, the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center will host the Midwest Symposium on New Concepts For Tissue-Specific Regenerative Medicine, Nov 17-18, 2012, in Rieveschl Auditorium of the Vontz Center for Molecular Studies.

6 Nov 2012

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.

5 Nov 2012

Study compares effectiveness of CABG surgery with PCI for adults with diabetes and heart disease

Adults with diabetes and multi-vessel coronary heart disease who underwent cardiac bypass surgery had better overall heart-related outcomes than those who underwent an artery-opening procedure to improve blood flow to the heart muscle, according to the results from an international study. The research was supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

5 Nov 2012

AeriSeal System appears to be effective in treating emphysema

Researchers at the University of Alabama at Birmingham injected a foam sealant into the lungs of a former smoker on Oct. 29, 2012, to treat his worsening emphysema. He was the first patient in the United States treated in a late-stage clinical trial of the AeriSeal System.

3 Nov 2012

Hospital for Special Surgery physical therapist offers marathon recovery tips

Close to 47,000 runners have spent the past several months training for the ING New York City Marathon. Once they have completed the race and achieved their goals, there are measures they can take to facilitate recovery, decrease post-race discomfort, and return to running without injury.

3 Nov 2012

Muscle News and Research

HCT 1026 may help stem debilitating effects of muscular dystrophy

Low antioxidant levels contribute to increased blood pressure during exercise for people with PAD

Exercise benefits physical, mental health in schizophrenia

Cardiac arrhythmias: an interview with Dr Andrew Grace

Better understanding of clotting dynamics in atherosclerosis could lead to more effective drugs

Nanofiber technique to build new nerves from stem cells

BMI may not be best measure for estimation of cancer risk

Scientists show how sorafenib can be dangerous to the heart

Economic impact of acute coronary syndrome goes beyond hospitals to homes and workplaces

Drug trio may reduce eliminate cardiac side effects of doxorubicin

Degeneration of serotonergic neurons linked to spasticity in ALS

Loyola announces 2012 Junior and Senior Scientist of the Year during St. Albert's Day

Positive results from BioCardia's Helical Infusion System Phase 1/2 trial on ischemic cardiomyopathy

Turning off GSK-3α protein activity can prevent heart remodeling

Physical exercise may help preserve mobility in Parkinson’s patients

Midwest symposium to discuss new concepts for tissue-specific regenerative medicine

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Study compares effectiveness of CABG surgery with PCI for adults with diabetes and heart disease

AeriSeal System appears to be effective in treating emphysema

Hospital for Special Surgery physical therapist offers marathon recovery tips

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News